Prostate cancer treament from Pittsboro pharma startup lands patent
Development-stage pharmaceutical startup Propella Therapeutics Inc. has just received a patent for its metastatic prostate cancer treatment, PRL-02. Here are the details.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
